| Vincent Giani, | |
|
56-119 Pualalea St, Kahuku, HI 96731-2052 | |
| (808) 293-9231 | |
| Not Available |
| Full Name | Vincent Giani |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 56-119 Pualalea St, Kahuku, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023462090 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 20309 (Hawaii) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kahuku Medical Center | Kahuku, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ko Olauloa Health Center | 0941259394 | 6 |
News Archive
Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced the results of an independent human clinical study that demonstrated intake of its proprietary Ambrotose AO capsules raised antioxidant protection in serum oxygen radical absorbance capacity in healthy adults, further validating a previous human study.
Chronic pain or pain that persists or recurs for longer than three months in children is a significant public health problem and a leading cause of morbidity in children globally.
Lead hazards in consumer products aren't limited to the millions of toys recalled so far this year, according to test results and a four-month investigation published in the December issue of Consumer Reports magazine.
Consistently maintaining certain blood levels of markers of bone metabolism and disease can prolong the lives of patients on hemodialysis, according to a study appearing in the September 2008 issue of the Clinical Journal of the American Society Nephrology (CJASN).
Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.
› Verified 7 days ago
| Entity Name | Ko Olauloa Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528026952 PECOS PAC ID: 0941259394 Enrollment ID: O20050112001130 |
News Archive
Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced the results of an independent human clinical study that demonstrated intake of its proprietary Ambrotose AO capsules raised antioxidant protection in serum oxygen radical absorbance capacity in healthy adults, further validating a previous human study.
Chronic pain or pain that persists or recurs for longer than three months in children is a significant public health problem and a leading cause of morbidity in children globally.
Lead hazards in consumer products aren't limited to the millions of toys recalled so far this year, according to test results and a four-month investigation published in the December issue of Consumer Reports magazine.
Consistently maintaining certain blood levels of markers of bone metabolism and disease can prolong the lives of patients on hemodialysis, according to a study appearing in the September 2008 issue of the Clinical Journal of the American Society Nephrology (CJASN).
Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vincent Giani, 56-119 Pualalea St, Kahuku, HI 96731-2052 Ph: () - | Vincent Giani, 56-119 Pualalea St, Kahuku, HI 96731-2052 Ph: (808) 293-9231 |
News Archive
Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced the results of an independent human clinical study that demonstrated intake of its proprietary Ambrotose AO capsules raised antioxidant protection in serum oxygen radical absorbance capacity in healthy adults, further validating a previous human study.
Chronic pain or pain that persists or recurs for longer than three months in children is a significant public health problem and a leading cause of morbidity in children globally.
Lead hazards in consumer products aren't limited to the millions of toys recalled so far this year, according to test results and a four-month investigation published in the December issue of Consumer Reports magazine.
Consistently maintaining certain blood levels of markers of bone metabolism and disease can prolong the lives of patients on hemodialysis, according to a study appearing in the September 2008 issue of the Clinical Journal of the American Society Nephrology (CJASN).
Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.
› Verified 7 days ago
Dr. Thomas Sperandeo, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 57-101 W Kuilima Loop Apt 163, Kahuku, HI 96731 Phone: 808-349-5692 Fax: 848-210-9601 | |
Dr. Jeff D. Smith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 56-565 Kamehameha Hwy, Kahuku, HI 96731 Phone: 808-432-3900 | |
Dr. Irene Hwang, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 56-119 Pualalea St, Kahuku, HI 96731 Phone: 808-293-9261 | |
Tarah L Henderson-toderic, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 56-117 Pualalea St, Kahuku, HI 96731 Phone: 706-414-4731 | |
Stephan Lebamoff, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 56-117 Pualalea St, Kahuku, HI 96731 Phone: 808-293-9221 Fax: 808-293-6290 |